Dr. Concepcion Vicenta Llorente Cortes | Biomedical | Best Researcher Award

Dr. Concepcion Vicenta Llorente Cortes | Biomedical | Best Researcher Award

Doctorate at Consejo Superior de Investigaciones Científicas, Spain

👨‍🎓 Profiles

Scopus

Orcid

Publications

PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia

  • Authors: Borràs, C., Canyelles, M., Girona, J., Blanco-Vaca, F., Escolà-Gil, J.C.
  • Journal: JACC: Basic to Translational Science
  • Year: 2024

sICAM-1 concentrations are associated with inflammation in contralateral carotid plaque in patients with ischemic stroke

  • Authors: Puig, N., Camps-Renom, P., Garcia, E., Llorente-Cortés, V., Benitez, S.
  • Journal: Clinica e Investigacion en Arteriosclerosis
  • Year: 2024

Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis

  • Authors: La Chica Lhoëst, M.T., Martinez, A., Claudi, L., Escolà-Gil, J.C., Llorente-Cortés, V.
  • Journal: Frontiers in Cardiovascular Medicine
  • Year: 2024

Transcriptional analysis reveals that the intracellular lipid accumulation impairs gene expression profiles involved in insulin response-associated cardiac functionality

  • Authors: Actis Dato, V., Paz, M.C., Rey, F.E., Chiabrando, G.A., Ceschin, D.G.
  • Journal: Scientific Reports
  • Year: 2023

Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke

  • Authors: Garcia, E., Camps-Renom, P., Puig, N., Benitez, S., Llorente-Cortés, V.
  • Journal: Journal of Translational Medicine
  • Year: 2023

Dr. Suprit Dilip Saoji | Biomedical | Best Researcher Award

Dr. Suprit Dilip Saoji | Biomedical | Best Researcher Award

Doctorate at Dr Reddys Laboratories Ltd, India

Profiles

Scopus

Orcid

Google Scholar

Summary

Dr. Suprit Dilip Saoji is a highly accomplished pharmaceutical professional with nearly a decade of experience in the pharmaceutical industry. He specializes in product ideation, selection, and lifecycle management, expertly guiding products from concept to successful launch. His strong skills in market research, financial analysis, and stakeholder management enable him to make informed strategic decisions that drive growth in both regulatory and emerging markets.

Education

  • Post Graduate Diploma in Patent Law
    Nalsar University of Law, Hyderabad (2021-2022)
  • Ph.D. in Pharmaceutical Sciences
    Nagpur University, Nagpur (2013-2015)
  • Master of Pharmacy (Pharmaceutics)
    Amravati University, Amravati (2009-2011)
  • Bachelor of Pharmacy
    Amravati University, Amravati (2005-2009)

💼 Professional Experience

  • Dr. Reddy’s Laboratories (Jun 2023 – Present)
    Product Ideation & Selection Specialist

    • Drives product ideation and stakeholder management, crafts strategic product roadmaps, and conducts market analyses to identify opportunities for new pharmaceutical products.
  • Slayback Pharma (Sept 2020 – Jun 2023)
    Manager, Formulation Development

    • Developed patented formulations for anti-cancer therapies and executed pilot bio-studies, showcasing a strong innovation drive.
  • Granules India Ltd (May 2019 – Sept 2020)
    Assistant Manager, Formulation Development

    • Successfully managed scale-up and market readiness for several pharmaceutical products in international markets.
  • Alkem Laboratories (Feb 2016 – May 2019)
    Senior Scientist, Formulation Development

    • Led the development of extended-release formulations, achieving USFDA approval during his tenure.

🔬 Research Interests

Dr. Saoji is particularly interested in innovative drug delivery systems and formulation strategies for chronic conditions like cancer and neuropathic pain. His research aims to bridge the gap between scientific feasibility and market demand, enhancing therapeutic outcomes. 

 

Publications

Eco synthesized chitosan/zinc oxide nanocomposites as the next generation of nano-delivery for antibacterial, antioxidant, antidiabetic potential, and chronic wound repair

  • Authors: Diksha Halarnekar, Muniappan Ayyanar, Peramaiyan Gangapriya, Mohan Kalaskar, Vivek Redasani, Nilambari Gurav, Sameer Nadaf, Suprit Saoji, Nilesh Rarokar, Shailendra Gurav
  • Journal: International Journal of Biological Macromolecules
  • Year: 2023

Preparation and formula optimization of cephalexin loaded transferosomal gel by QbD to enhance the transdermal delivery: in vitro, ex vivo and in vivo study

  • Authors: Nilesh R Rarokar, Suprit D Saoji, Nishika V Deole, Madhuri Gaikwad, Abhijeet Pandey, Chinnaperumal Kamaraj, Suresh V Chinni, Vetriselvan Subramaniyan, Gopinath Ramachawolran, Sanket Dharashivkar
  • Journal: Journal of Drug Delivery Science and Technology
  • Year: 2023

Magnetic nanosystem a tool for targeted delivery and diagnostic application: Current challenges and recent advancement

  • Authors: Nilesh Rarokar, Sakshi Yadav, Suprit Saoji, Pratiksha Bramhe, Rishab Agade, Shailendra Gurav, Pramod Khedekar, Vetriselvan Subramaniyan, Ling Shing Wong, Vinoth Kumarasamy
  • Journal: International Journal of Pharmaceutics: X
  • Year: 2024

Ethnological validation of Ashwagandha (Withania somnifera L. Dunal) ghrita as ‘Vajikarana Rasayana’: In-silico, in-vitro and in-vivo approach

  • Authors: Shailendra Gurav, Manish Wanjari, Ritesh Bhole, Nishikant Raut, Satyendra Prasad, Suprit Saoji, Rupesh Chikhale, Pukar Khanal, Amit Pant, Muniappan Ayyanar, Nilambari Gurav
  • Journal: Journal of Ethnopharmacology
  • Year: 2023

Ethnological validation of Ashwagandha (Withania somnifera L. Dunal) ghrita as ‘Vajikarana Rasayana’: In-silico, in-vitro and in-vivo approach

  • Authors: Shailendra Gurav, Manish Wanjari, Ritesh Bhole, Nishikant Raut, Satyendra Prasad, Suprit Saoji, Rupesh Chikhale, Pukar Khanal, Amit Pant, Muniappan Ayyanar, Nilambari Gurav
  • Journal: Journal of Ethnopharmacology
  • Year: 2023

Ms. Shreya Agarwal | Biomedical | Best Researcher Award

Ms. Shreya Agarwal | Biomedical | Best Researcher Award

Shreya Agarwal at University of Freiburg, Germany

Profiles

Google Scholar

Academic Background

Ms. Shreya Agarwal is a dedicated Life Scientist with a Master’s in Neuroscience and a passion for advancing our understanding of the brain. With substantial experience in laboratory research, she excels in data analysis, microscopy, molecular biology, and genetics. Known for her strong organizational skills and ability to manage multiple projects with precision, Shreya is committed to contributing to her team’s success and taking on new challenges.

Education

Master of Science (M.Sc.) in Molecular and Translational Neurosciences
University of Ulm, Germany (2021)
Thesis: “Study of the mutation KIF5A in ALS, which promotes protein aggregation”

Bachelor of Science (B.Sc.) in Neurosciences
Amity University, Noida, India (2019)
Thesis: “The role of chronic hypobaric hypoxia in the development of cognitive impairment”

Work Experience

PhD Student, Biomikrotechnik
Institut für Mikrosystemtechnik – IMTEK, Albert-Ludwigs-Universität Freiburg (Since 10.2023)
Researching network development and spatial embedding of inhibitory neurons.

Research Associate
Institute of Anatomy and Cell Biology, University of Ulm (01.2022 – 03.2023)
Investigated synaptic aging in Alzheimer’s and ALS; led tutoring and scientific discussions.

Research Assistant
Institute of Anatomy and Cell Biology, University of Ulm (01.2021 – 04.2021)
Assisted in experiments, maintained research records, and implemented data analysis software.

Training and Internship
Center for Clinical Research, University Clinic for Neurology, Ulm (10.2020 – 11.2020)
Studied clinical drug development and principles of pharmacokinetics.

Student Research Intern
Institute for Physiological Chemistry, University of Ulm (08.2020 – 10.2020)
Analyzed mouse models for NF kappa B expression and receptor tyrosine kinase investigation.

📚 Certifications

FELASA – Laboratory Animal Science Course (11.2023)
Project Management by IGradU (02.2023)
Scientific Writing and Presentation Skills (IGradU, 2022)
Writing in the Sciences by Stanford (07.2021)
Drug Discovery and Development by UC San Diego (12.2020)

🏆 Awards

STIBET Scholarship by Ulm University and DAAD (2020 – 2021)

🔧 Skills

Cell culture techniques, qPCR, Western Blot, Immunocytochemistry
Data analysis software including MATLAB, GraphPad Prism, ImageJ

Publications

Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer’s disease
  • Authors: Shampa Ghosh, Shantanu Durgvanshi, Shreya Agarwal, Manchala Raghunath, Jitendra K Sinha
  • Journal: Current neuropharmacology
  • Year: 2020
Long-Term Potentiation
  • Authors: Jitendra Kumar Sinha, Shreya Agarwal, Shampa Ghosh
  • Year: 2022
Pituitary Gland
  • Authors: S Ghosh, S Durgvanshi, S Agarwal, JK Sinha
  • Journal: Encyclopedia of Animal Cognition and Behavior
  • Year: 2019

Prof. Dal-Hee Min | Biomedical | Best Researcher Award

Prof. Dal-Hee Min, Biomedical, Best Researcher Award

Dal-Hee Min at Seoul National University, South Korea

Profiles

Scopus

Orcid

Google Scholar

 

👩‍🔬 Academic Career and Research Focus 

Dal-Hee Min, currently a distinguished Professor at Seoul National University and co-founder of Lemonex Inc., has forged an illustrious path in the realms of mRNA vaccines, gene therapy, and nanobiotechnology. With a solid foundation laid during her doctoral studies at the University of Chicago and subsequent postdoctoral research at MIT, she embarked on an academic journey that began at KAIST as an Assistant Professor in 2007. Transitioning to Seoul National University in 2011 marked a pivotal move in her career trajectory.

🏆 Awards and Recognition 

Dal-Hee Min’s contributions have been celebrated with numerous accolades, including the prestigious KCS-Wiley Young Chemist Award, the Korea L’Oreal UNESCO Fellowship Award for Women in Science, and the esteemed Order of Science and Technology Merit (Do-Yak Medal) from the Korean Government. These recognitions underscore her significant impact and leadership in the field of nanomedicine and drug delivery systems.

🌍 Global Engagement and Leadership 

Actively engaged in global scientific discourse, Dal-Hee Min has been a featured speaker at prominent venues such as the World Economic Forum, where she highlighted cutting-edge DDS technology. Her impactful presentations at international conferences like PODD, JP Morgan, and BIO USA underscore her role as a thought leader in advancing biotechnological frontiers.

🎓Education and Professional Development

Dal-Hee Min’s academic journey is anchored by a robust educational background, including a Ph.D. in Chemistry from the University of Chicago and a master’s degree from Seoul National University. Her formative years at MIT as a postdoctoral researcher solidified her expertise in bioengineering, laying the groundwork for her pioneering research in nanomaterials and biomedical applications.

🔬📈 Innovative Research and Collaborations 

At the forefront of her research endeavors are groundbreaking studies in drug delivery systems, leveraging nano-surface chemistry for applications ranging from mRNA vaccines to gene therapies. Her collaborative efforts have yielded impactful publications in top-tier journals, underscoring her commitment to advancing therapeutic modalities through innovative nanotechnological solutions.

📖 Publications:

Bio-inspired interfacial chemistry for the fabrication of a robust and functional graphene oxide composite film
  • Authors: Kwon, Y.-B., Cho, S., Min, D.-H., Kim, Y.-K.
  • Journal: RSC Advances
  • Year: 2024
Enhanced Local Delivery of Engineered IL-2 mRNA by Porous Silica Nanoparticles to Promote Effective Antitumor Immunity
  • Authors: Shin, H., Kang, S., Won, C., Min, D.-H.
  • Journal: ACS Nano
  • Year: 2023
3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing
  • Authors: Ahn, J., Kim, D.-H., Koo, D.-J., Kim, Y., Jeon, N.L.
  • Journal: Acta Biomaterialia
  • Year: 2023
Rod-to-sphere elemental reconstruction of biocompatible Ag2Te-Ag4.53-Te3 nanoparticles for triple negative breast cancer photo-nano-therapy
  • Authors: Ahn, H., Kang, S., Kang, K., Min, D.-H., Jang, H.
  • Journal: Journal of Materials Chemistry B
  • Year: 2023
Highly Efficient Messenger RNA Transfection of Hard-to-Transfect Cells using Carbon Nanodots
  • Authors: Shin, H., Min, D.-H.
  • Journal: Shin, H., Min, D.-H.
  • Year: 2023